|
Originally published In Press as doi:10.1074/jbc.M408525200 on December 20, 2004
J. Biol. Chem., Vol. 280, Issue 8, 6602-6609, February 25, 2005
Proteolytic N-terminal Truncation of Cardiac Troponin I Enhances Ventricular Diastolic Function*
John C. Barbato ,
Qi-Quan Huang¶,
M. Moazzem Hossain ¶,
Meredith Bond ||, and
Jian-Ping Jin ¶**
From the
¶Section of Molecular Cardiology, Evanston Northwestern Healthcare, Northwestern University Feinberg School of Medicine, Evanston, Illinois 60201, the Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, and the ||Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201
Besides the core structure conserved in all troponin I isoforms, cardiac troponin I (cTnI) has an N-terminal extension that contains phosphorylation sites for protein kinase A under -adrenergic regulation. A restricted cleavage of this N-terminal regulatory domain occurs in normal cardiac muscle and is up-regulated during hemodynamic adaptation (Z.-B. Yu, L.-F. Zhang, and J.-P. Jin (2001) J. Biol. Chem. 276, 1575315760). In the present study, we developed transgenic mice overexpressing the N-terminal truncated cTnI (cTnI-ND) in the heart to examine its biochemical and physiological significance. Ca2+-activated actomyosin ATPase activity showed that cTnI-ND myofibrils had lower affinity for Ca2+ than controls, similar to the effect of isoproterenol treatment. In vivo and isolated working heart experiments revealed that cTnI-ND hearts had a significantly faster rate of relaxation and lower left ventricular end diastolic pressure compared with controls. The higher baseline relaxation rate of cTnI-ND hearts was at a level similar to that of wild type mouse hearts under -adrenergic stimulation. The decrease in cardiac output due to lowered preload was significantly smaller for cTnI-ND hearts compared with controls. These findings indicate that removal of the N-terminal extension of cTnI via restricted proteolysis enhances cardiac function by increasing the rate of myocardial relaxation and lowering left ventricular end diastolic pressure to facilitate ventricular filling, thus resulting in better utilization of the Frank-Starling mechanism.
Received for publication, July 27, 2004
, and in revised form, November 3, 2004.
* This study was supported in part by National Aeronautics and Space Administration Grant NAG 2-1598, NIAMS, National Institutes of Health (NIH), Grant AR-048816 (to J-P. J.), NHLBI, NIH, Grant HL-56256, and NIA, NIH, Grant AG-16613 (to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported in part by NIH Grant T32-HL07653.
** To whom correspondence should be addressed. Tel.: 847-570-1960; Fax: 847-570-1865; E-mail: jpjin{at}northwestern.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. K. McConnell, Z. Popovic, N. Mal, K. Lee, J. Bautista, F. Forudi, R. Schwartzman, J.-P. Jin, M. Penn, and M. Bond
Disruption of Protein Kinase A Interaction with A-kinase-anchoring Proteins in the Heart in Vivo: EFFECTS ON CARDIAC CONTRACTILITY, PROTEIN KINASE A PHOSPHORYLATION, AND TROPONIN I PROTEOLYSIS
J. Biol. Chem.,
January 16, 2009;
284(3):
1583 - 1592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Z. Feng, M. Chen, L. S. Weinstein, and J.-P. Jin
Removal of the N-terminal Extension of Cardiac Troponin I as a Functional Compensation for Impaired Myocardial {beta}-Adrenergic Signaling
J. Biol. Chem.,
November 28, 2008;
283(48):
33384 - 33393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Z. Feng, B. J. Biesiadecki, Z.-B. Yu, M. M. Hossain, and J.-P. Jin
Restricted N-terminal truncation of cardiac troponin T: a novel mechanism for functional adaptation to energetic crisis
J. Physiol.,
July 15, 2008;
586(14):
3537 - 3550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Du, J. Liu, H.-Z. Feng, M. M. Hossain, N. Gobara, C. Zhang, Y. Li, P.-Y. Jean-Charles, J.-P. Jin, and X.-P. Huang
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2604 - H2613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sadayappan, N. Finley, J. W. Howarth, H. Osinska, R. Klevitsky, J. N. Lorenz, P. R. Rosevear, and J. Robbins
Role of the acidic N' region of cardiac troponin I in regulating myocardial function
FASEB J,
April 1, 2008;
22(4):
1246 - 1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-Q. Huang, H. Z. Feng, J. Liu, J. Du, L. B. Stull, C. S. Moravec, X. Huang, and J.-P. Jin
Co-expression of skeletal and cardiac troponin T decreases mouse cardiac function
Am J Physiol Cell Physiol,
January 1, 2008;
294(1):
C213 - C222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Jweied, R. D. McKinney, L. A. Walker, I. Brodsky, A. S. Geha, M. G. Massad, P. M. Buttrick, and P. P. de Tombe
Depressed cardiac myofilament function in human diabetes mellitus
Am J Physiol Heart Circ Physiol,
December 1, 2005;
289(6):
H2478 - H2483.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|